### ðŸ«  Arrhythmias: Atrioventricular Nodal Reentrant Tachycardia Diagnosis

#### âœ… True Statements
1. **Atrioventricular nodal reentrant tachycardia (AVNRT)** is the most common form of **supraventricular tachycardia (SVT)**.
2. **AVNRT** is caused by a **reentrant circuit within the atrioventricular (AV) node** that uses both **fast and slow conduction pathways**.
3. Electrocardiographic features of **AVNRT** include a **regular narrowâ€‘complex tachycardia**, a **short RP interval**, and a **retrograde P wave** located immediately adjacent to the **QRS complex**.
4. **Orthodromic atrioventricular reciprocating tachycardia (AVRT)** presents with a **narrow QRS complex** and discernible **P waves**, whereas **antidromic AVRT** presents with a **wide QRS complex** and P waves.
5. The **absence of visible P waves** on ECG helps distinguish **AVNRT** from **sinus tachycardia, atrial fibrillation,** and **AVRT**.

#### ðŸ’¬ Extra
1. AVNRT comprises roughly **two thirds of SVT cases** when atrial fibrillation and atrial flutter are excluded.
2. The **fast pathway** conducts impulses rapidly but has a long refractory period; the **slow pathway** conducts more slowly but has a shorter refractory period, enabling the reentry loop.
3. A retrograde P wave that is inscribed so close to the QRS complex may be hidden within or immediately after the QRS, making it difficult to see.
4. Recognizing the QRS width and Pâ€‘wave relationship assists in differentiating AVRT subtypes during tachycardia evaluation.
5. **Sinus tachycardia** and **atrial fibrillation** produce visible **P waves** or irregular Râ€“R intervals, features not seen in AVNRT.

#### ðŸ”· Tags
#Cardiology #Arrhythmia #SupraventricularTachycardia #AVNRT #AmbulatoryCare #EmergentCare #Pregnancy

#### ðŸ“™ Reference
Brugada J, Katritsis DG, Arbelo E, etÂ al; ESC Scientific Document Group. 2019 ESC guidelines for the management of patients with supraventricular tachycardia. *Eur Heart J*. 2020;41:655â€‘720. PMID:Â 31504496 doi:10.1093/eurheartj/ehz467

#### ðŸ†” Question ID
CVVDX24056

#### ðŸ•’ Last Updated
FebruaryÂ 2025

---

#### ðŸ“– Related Text
MKSAPÂ 19: Cardiovascular Medicine â€” Arrhythmias, Supraventricular Tachycardias, Atrioventricular Nodal Reentrant Tachycardia

---

### ðŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Atrioventricular nodal reentrant tachycardia (AVNRT)** accounts for approximately **two thirds of supraventricular tachycardia cases**, excluding **atrial fibrillation** and **atrial flutter**.
2. **Vagal maneuvers** or **intravenous adenosine** can acutely terminate episodes of **AVNRT**.
3. Chronic prevention of recurrent **AVNRT** episodes can be achieved with **Î²â€‘blockers** or **nonâ€‘dihydropyridine calcium channel blockers**.
4. **Catheter ablation** is considered **firstâ€‘line therapy** for **AVNRT** in patients who do not tolerate or wish to avoid longâ€‘term medical therapy.
5. **Catheter ablation of AVNRT** has a **high success rate** but carries a **<1% risk of atrioventricular node injury** that may require permanent pacemaker implantation.

#### ðŸ’¬ Extra
1. This high prevalence underscores the importance of recognizing AVNRT among regularâ€‘narrowâ€‘complex tachycardias.
2. **Adenosine** transiently blocks AV nodal conduction, interrupting the reentry circuit.
3. These medications slow AV nodal conduction and increase refractoriness, inhibiting reentry.
4. Ablation targets the **slow pathway** region to eliminate the reentry circuit while preserving normal conduction.
5. AV node damage during ablation is uncommon but clinically significant and should be discussed during consent.

#### ðŸ”· Tags
#AVNRT #SupraventricularTachycardia #VagalManeuver #Adenosine #BetaBlocker #CalciumChannelBlocker #CatheterAblation #Arrhythmia
